I. The Substance

Caffeine is a central nervous system stimulant of the methylxanthine class, and it is the most widely consumed psychoactive drug in the world. It is legal and unregulated in nearly all parts of the world.¹ That sentence is not a rhetorical flourish. It is the standard scientific description of the substance, reproduced in the peer-reviewed literature and on the public encyclopedia alike, and it is worth reading slowly, because everything that follows is built on it.

The pharmacology is direct. Ingested caffeine is water- and lipid-soluble, so it crosses the blood-brain barrier. Inside the brain, its chemical structure closely resembles that of adenosine, the molecule whose accumulation across the day activates the neural receptors that promote sleep. Caffeine occupies those receptors instead, blocking them, and the net effect is wakefulness.² The mechanism of action is receptor blockade inside the human brain. This is what psychoactive drugs do.

The origin story is no softer. Caffeine occurs naturally in the leaves, seeds, or fruit of more than sixty plant species, including coffee beans, tea leaves, cacao beans, kola nuts, guarana seeds, and yerba mate leaf. In plants, caffeine acts as a natural pesticide. It paralyzes and kills insects that attempt to feed on them.³ The substance in the morning cup is, botanically speaking, an insecticide.

The scale of consumption is close to universal. Eight in ten humans consume a caffeinated beverage daily. As of recent surveys, eighty-five percent of American adults consume some form of caffeine daily, averaging about 164 milligrams.¹² The International Coffee Organization reports about nine million tons of coffee consumed in various forms in a single year.¹ The half-life of a dose in the body is three to seven hours, meaning the morning drug is still pharmacologically active at dinner.²

II. The Dose

The Food and Drug Administration has cited four hundred milligrams a day, roughly two to three twelve-ounce cups of coffee by the agency’s own arithmetic, as an amount “not generally associated with dangerous negative effects” for most adults. The agency adds that there is wide variation in how sensitive people are to caffeine and how fast they eliminate it, that certain conditions and medications make people more sensitive, and that it has not set any level at all for children; the American Academy of Pediatrics discourages the consumption of caffeine and other stimulants by children and adolescents.⁴

Here is the arithmetic the industry declines to print. The FDA’s cited amount, 400 milligrams, is the daily figure for a healthy adult. A single large brewed coffee from a chain outlet can contain most of that in one cup. The cups carry no milligram disclosure. A consumer ordering a “grande” or a “venti” is ordering a brand, not a dose. No pharmacy in America would dispense a central nervous system stimulant in unmarked cups measured by marketing names. Every coffee shop in America does.

The young receive no protection that the agency can name. Teenagers consume about one-third the caffeine adults do, according to FDA figures.⁵ The agency has concerns, on the record, about manufacturers adding caffeine to gum, candy, waffles, water, syrup, marshmallows, and sunflower seeds, products described in the trade press as “psyched up” oatmeal and “wired” waffles, with the concern stated as applying especially to children and adolescents.³ Concern, expressed. Enforcement, not commenced.

III. The Diagnosis

The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, includes caffeine as one of the ten substances in its chapter on substance-related and addictive disorders. Five caffeine-related disorders are specifically enumerated: caffeine intoxication (305.90), caffeine withdrawal (292.0), caffeine-induced anxiety disorder, caffeine-induced sleep disorder, and unspecified caffeine-related disorder.⁶

The criteria are clinical and precise. Caffeine intoxication is defined as recent consumption of caffeine, typically a high dose well in excess of 250 milligrams, accompanied by at least five of twelve signs or symptoms during or shortly after use: restlessness, nervousness, excitement, insomnia, flushed face, diuresis, gastrointestinal disturbance, muscle twitching, rambling flow of thought and speech, tachycardia or cardiac arrhythmia, periods of inexhaustibility, and psychomotor agitation.⁶ The DSM-5 itself notes that caffeine is the most widely used, behaviorally active drug in the world, and that some consumers may be unaware of their physical dependence on it.⁷

Caffeine withdrawal, newly enumerated in the DSM-5, is diagnosed by the headache, fatigue, difficulty concentrating, and depressed mood that follow the abrupt reduction of the daily dose.⁷ The symptoms of dependence are transitory, say the defenders of the status quo. The symptoms of dependence exist, say the manual.

The emergency departments have noticed. Emergency room visits resulting from caffeine-rich energy drinks doubled between 2007 and 2011, according to the Substance Abuse and Mental Health Services Administration.⁵ The worst cases of caffeine overdose have led to death.⁵ The substance now sits in the federal manual alongside heroin and alcohol dependence, classified as a disorder-producing drug. The queue at the drive-through suggests the diagnosis has not yet reached the consumers.

IV. The Precedent

The agency has done this before, for a lesser substance. In February 2004, the Food and Drug Administration published a final rule prohibiting the sale of dietary supplements containing ephedrine alkaloids, the stimulant derived from the ephedra plant, effective April 12, 2004. The agency concluded that the risks were unreasonable in light of any benefits.⁸ The rule’s authority ran under the Dietary Supplement Health and Education Act, which required the agency to demonstrate a significant or unreasonable risk before acting. The FDA cited significant cardiovascular risk, noted that ephedrine had been likened to other sympathomimetics and controlled stimulants, and pulled the products from the market.⁹ The adverse events reviewed by the agency included ten deaths and thirteen cases of permanent disability.¹⁰

The same agency knows what concentrated caffeine can do, because it has buried the victims. On May 27, 2014, eighteen-year-old Logan Stiner of LaGrange, Ohio, died after consuming pure powdered caffeine; the county coroner found more than seventy micrograms of caffeine per milliliter in his blood, as much as twenty-three times the level of a typical coffee drinker. One month later, twenty-four-year-old Wade Sweatt of Alpharetta, Georgia, died of cardiac arrest after accidentally ingesting too much of the powder.¹¹ The FDA warned consumers to avoid the products, noting that a single teaspoon of pure powdered caffeine is equivalent to about twenty-five cups of coffee, that the products are nearly one hundred percent caffeine and may carry minimal or insufficient labeling, and that the difference between a safe amount and a lethal dose is very small.¹² In 2015 the agency sent warning letters to five distributors, stating that the products present a significant or unreasonable risk of illness or injury.¹³

The arithmetic of the retail packet was later laid before Congress. A typical 250-gram packet of caffeine powder costs less than twenty dollars and contains the equivalent of 2,500 cups of regular coffee, enough pure caffeine to cause the deaths of fifty people. The recommended dose is one-sixteenth of a teaspoon, which is nearly impossible for a typical consumer to measure with common kitchen tools. Suffolk County, New York became the first jurisdiction in the country to restrict the retail sale of bulk caffeine powder.¹⁴ The federal ban did not follow. The agency knew the lethal dose, knew the packet math, and left the coffee untouched.

V. The Distribution Network

Starbucks Corporation, the nation’s largest single distributor of the drug, reported 16,864 stores in the United States at the close of its 2025 fiscal year, comprising forty-one percent of its 40,990 stores worldwide.¹⁵ To this figure must be added every Dunkin’ outlet, every McDonald’s counter, every gas station urn, every office break room, and every drive-through in the fifty states. The network is the densest retail distribution grid for any psychoactive substance on earth.

None of it is licensed as such. No federal statute requires an age check for the purchase of brewed coffee. No state requires a prescription. No cup discloses the milligram content. The barista requires no pharmaceutical training, no dispensing license, no controlled-substance registration. The green apron is the only uniform in American retail under which a central nervous system stimulant, listed in the DSM-5 with recognized intoxication and withdrawal disorders, is handed to children in unmarked doses for cash.

VI. Ergo

Consider the profile, assembled from the evidence above. The substance is a central nervous system stimulant, the most widely consumed psychoactive drug in the world, consumed daily by eighty-five percent of American adults. Its mechanism is the blockade of adenosine receptors inside the brain. Its intoxication and withdrawal are recognized mental disorders with diagnostic codes. Its concentrated form has a documented lethal dose, killed two young men in two months in 2014, and is sold at retail in packets containing fifty fatal doses for less than twenty dollars. Its distributor class was once removed from the market, in 2004, when the agency decided a weaker stimulant presented an unreasonable risk. Its pediatric use is discouraged by the nation’s pediatricians and left unregulated by everyone else.

Any other substance with this profile would be scheduled, prescription-gated, age-restricted, and dose-labeled. This one is sold to fourteen-year-olds in twenty-ounce cups with a cardboard sleeve. The largest unlicensed psychoactive-drug distribution operation in American history does not hide in the shadows. It hides in plain sight, in the morning line, and it wears a green apron.